C2i Genomics revolutionizes cancer treatment by providing real-time monitoring of cancer recurrence and progression through advanced whole-genome analysis of subtle DNA changes in tumors.
Headquarters:
United States of America
Company Type:
SME
Company size:
11-50 Employees
Address:
NEW YORK, NY, US
LOW
spending power
